Although metformin can be taken alone, it’s frequently used alongside lifestyle changes, including diet and exercise. It also increases the body’s response to insulin. Metformin is often used by type 2 diabetes patients to help manage the amount of glucose in the blood, decreasing the amount of sugar absorbed from food and produced in the liver, according to the National Institutes of Health ( NIH). It’s been shown to cause tumors in rodents, meaning it also likely causes cancer in humans. Symptoms of overexposure include headache, fever, nausea, jaundice, vomiting, cramps, enlarged liver, and dizziness, the EPA explains. Multiple pharmaceutical companies manufacture metformin, but this recall affects only Viona’s products.Įxposure to high levels of NDMA may cause liver damage, the Environmental Protection Agency ( EPA) warns. You can find the full list of recalled lots here. They were shipped to distributors nationwide. The 23 recalled metformin lots are packaged in bottles of 100 pills and have expiration dates between June 2022 and January 2023. No adverse events have been reported yet. Testing revealed the impurity in one lot, and the statement indicates that the rest are likely affected, too. NDMA is an environmental contaminant classified as a probable human carcinogen, the FDA says. Allow your medical professional know if you are taking such medicines as nicotinic acid, ranitidine, phenytoin, medicines for thyroid gland disease, furosemide, blood insulin or various other medicines for diabetic issues, oral birth control methods, medications for asthma and frosts, beta-blockers, oral anabolic steroids, cimetidine, quinidine. The recall impacts 23 lots of Viona’s metformin drug, which likely contains unacceptable levels of the impurity N-nitrosodimethylamine (NDMA), per the Food and Drug Administration’s (FDA) January 12 announcement. is recalling several lots of the popular medication Metformin Hydrochloride Extended-Release Tablets, USP 750 mg (often used to treat type 2 diabetes) over a potentially cancer-causing impurity. The pharmaceutical company also recalled two lots of metformin in June 2021, citing the exact same carcinogenic impurity.Ĭheck your medicine cabinet: Viona Pharmaceuticals, Inc.is voluntarily recalling 23 lots of Metformin Hydrochloride Extended-Release Tablets due to the presence of the probable carcinogen NDMA. 500 mg Imprint APO XR500 Color White Shape Capsule-shape View details. Search by imprint, shape, color or drug name. The FDA has announced the recall of one brand of a popular type 2 diabetes drug, metformin, over a potentially cancer-causing impurity. Drug Identifier results for 'metformin extended release'.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |